B & B Pharmaceuticals, Inc Receives FDA Warning Letter
Enforcement Report - Week of June 19, 2019
Enforcement Report - Week of April 25, 2018
As part of the agreement, AZ will sell the following brands of Bricarex, Bricarex-A, Bricanyl, Xylocard, Ceriviprime, Prostodin, Partocin and Primiprost in India to Zydus Healthcare, these brands were discontinued by the company in Indian market.
Indian pharma giant Cadila healthcare's arm Zydus Healthcare has acquired six brands from MSD Pharmaceuticals India Pvt. Ltd, the local arm of US-based Merck & Co Inc, for distribution in the Indian market. Cadila said in a statement here that the deal includes transfer of distribution and commercialisation rights and assignment of trademarks of all the six brands to Zydus Healthcare Limited in India.
ZydusBSE -0.29 % in a release late on Wednesday said it has acquired Deca-Durabolin, Durabolin, Sustanon, Multiload, Sicastat and Axeten range from Merck Sharp and Dohme (MSD).
Advanced Physician Solutions, Inc. initiates Class II recall of Nandrolone Decanoate due to Lack of Assurance of Sterility